| 12202842 |
MCL1 inhibitors |
Hang Chu, Juan A. Guerrero, Lan Jiang, Darryl Kato, Tetsuya Kobayashi +8 more |
2025-01-21 |
|
| 12187734 |
Substituted pyridotriazine compounds and uses thereof |
Hang Chu, Ana Z. Gonzalez Buenrostro, Hongyan Guo, Xiaochun Han, Lan Jiang +10 more |
2025-01-07 |
|
| 12162844 |
MCL-1 inhibitors |
Hang Chu, Juan A. Guerrero, Tae H. Hwang, Lan Jiang, Darryl Kato +14 more |
2024-12-10 |
$252,679,000 |
| 12054496 |
Bridged tricyclic carbamoylpyridone compounds and uses thereof |
Hang Chu, Ana Z. Gonzalez Buenrostro, Xiaochun Han, Lan Jiang, Jiayao Li +5 more |
2024-08-06 |
$110,474,000 |
| 12024528 |
Bridged tricyclic carbamoylpyridone compounds and uses thereof |
Hang Chu, Ana Z. Gonzalez Buenrostro, Xiaochun Han, Lan Jiang, Jiayao Li +5 more |
2024-07-02 |
$457,639,000 |
| 11897892 |
Substituted pyridotriazine compounds and uses thereof |
Hang Chu, Ana Z. Gonzalez Buenrostro, Hongyan Guo, Xiaochun Han, Lan Jiang +10 more |
2024-02-13 |
$118,355,000 |
| 11667652 |
MCL1 inhibitors |
Hang Chu, Juan A. Guerrero, Lan Jiang, Darryl Kato, Tetsuya Kobayashi +8 more |
2023-06-06 |
$568,374,000 |
| 11643400 |
MCL-1 inhibitors |
Hang Chu, Juan A. Guerrero, Tae H. Hwang, Lan Jiang, Darryl Kato +14 more |
2023-05-09 |
$305,124,000 |
| 11613546 |
Substituted pyridotriazine compounds and uses thereof |
Hang Chu, Ana Z. Gonzalez Buenrostro, Hongyan Guo, Xiaochun Han, Lan Jiang +10 more |
2023-03-28 |
$310,764,000 |
| 10988451 |
MCL-1 inhibitors |
Hang Chu, Juan A. Guerrero, Tae H. Hwang, Lan Jiang, Darryl Kato +14 more |
2021-04-27 |
$236,030,000 |
| 10703733 |
MCL-1 inhibitors |
Hang Chu, Juan A. Guerrero, Tae H. Hwang, Lan Jiang, Darryl Kato +14 more |
2020-07-07 |
$851,015,000 |